Medicare Enrolled

Dr. Norman Gaylis, M.D.

Rheumatology · Aventura, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
2801 NE 213TH ST STE 801, Aventura, FL 33180
3056526676
In practice since 2006 (19 years)
NPI: 1255440384 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gaylis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gaylis? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gaylis

Dr. Norman Gaylis is a rheumatology in Aventura, FL, with 19 years in practice. Based on federal Medicare data, Dr. Gaylis performed 224,392 Medicare services across 4,339 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gaylis received a total of $19,948 from 32 pharmaceutical and/or device companies across 166 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gaylis is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 7% volume in FL$ $19,948 industry payments

Medicare Practice Summary

Medicare Utilization ↗
224,392
Medicare services
Top 7% in FL for rheumatology
4,339
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~11,810 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Romosozumab injection (Evenity) for osteoporosis84,041$8$11
Tocilizumab injection (Actemra)46,210$5$7
Certolizumab injection (Cimzia)28,800$4$10
Denosumab injection (Prolia/Xgeva)25,085$18$27
Golimumab infusion (Simponi Aria)14,850$11$30
Infliximab infusion (Remicade)10,430$26$70
Injection, rituximab, 10 mg4,464$64$120
Physical therapy exercise, per 15 min1,605$20$50
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle1,084$58$100
Office visit, established patient (20-29 min)943$70$110
Manual therapy (hands-on treatment), per 15 min661$18$70
Office visit, established patient (30-39 min)619$101$168
Administration of chemotherapy into vein, 1 hour or less597$106$250
Administration of chemotherapy into vein, each additional hour482$24$60
Injection, methylprednisolone acetate, 80 mg413$9$25
Injection, methylprednisolone sodium succinate, up to 125 mg410$4$15
Dexamethasone injection (steroid)401$0$1
New patient office visit (45-59 min)243$134$254
Office visit, established patient (10-19 min)225$41$69
Bone density scan (DEXA)224$40$100
Refilling and maintenance of portable pump182$108$300
Neuromuscular re-education therapy, per 15 min182$25$47
Aspiration and/or injection of fluid large joint using ultrasound guidance181$96$246
Self-care/home management training, per 15 min178$21$43
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour173$17$100
X-ray of knee, 1-2 views151$28$78
Joint injection, major joint148$58$131
Injection, diphenhydramine hcl, up to 50 mg133$1$10
Functional activity therapy130$28$50
Infusion, normal saline solution, 250 cc123$1$30
Hyaluronan or derivative, monovisc, for intra-articular injection, per dose119$560$1,600
X-ray of hand, 2 views114$26$74
Shoulder X-ray, 2+ views107$29$67
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less90$54$125
X-ray of lower and sacral spine, 2-3 views76$33$87
Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19)70$41$55
Evaluation for physical therapy, typically 30 minutes67$83$137
Walking/gait training therapy, per 15 min59$19$120
Injection of trigger points, 1-2 muscles58$41$125
Electrical stimulation therapy53$8$60
X-ray of both hips, 2 views48$34$93
X-ray of upper spine, 2-3 views35$33$93
Therapy procedure using massage, each 15 minutes34$22$38
X-ray of foot, 2 views26$24$67
Aspiration and/or injection of fluid from medium joint using ultrasound guidance24$74$204
Injection into tendon or ligament17$41$132
Evaluation for physical therapy, typically 20 minutes15$84$117
Ultrasonic guidance for needle placement12$45$244
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.4% high complexity
85.9% medium
2.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$19,948
Total received (2018-2024)
Avg $2,850/year across 7 years
Top 23% in FL for rheumatology
32
Companies
166
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12,584 (63.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,829 (19.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,534 (17.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$674
2023
$14,837
2022
$457
2021
$854
2020
$169
2019
$372
2018
$2,584

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$12,652
Hexal AG
$2,200
Fresenius Kabi USA, LLC
$1,334
ABBVIE INC.
$426
GlaxoSmithKline, LLC.
$419
IntrinsiQ Specialty Solutions, Inc.
$363
Horizon Therapeutics plc
$255
Amgen Inc.
$245
PFIZER INC.
$239
E.R. Squibb & Sons, L.L.C.
$207
DePuy Synthes Sales Inc.
$169
AbbVie Inc.
$156
NOVARTIS PHARMACEUTICALS CORPORATION
$153
Janssen Biotech, Inc.
$146
Mallinckrodt LLC
$135
Octapharma USA, Inc.
$116
Genentech USA, Inc.
$100
Alvogen Inc
$82
Aurinia Pharma U.S., Inc.
$71
Radius Health, Inc.
$68
Mallinckrodt Enterprises LLC
$58
Mallinckrodt Hospital Products Inc.
$51
Boston Scientific Corporation
$48
AbbVie, Inc.
$45
Exeltis, USA Inc.
$38
Janssen Scientific Affairs, LLC
$35
ANI Pharmaceuticals, Inc.
$34
Genentech, Inc.
$26
UCB, Inc.
$25
Orthogenrx Inc.
$19
Lilly USA, LLC
$17
AstraZeneca Pharmaceuticals LP
$15
Top 3 companies account for 81.1% of total payments
Associated products mentioned in payments ›
ACTHAR · Actemra · BENLYSTA · BOTOX · COSENTYX · CUTAQUIG · Cimzia · EVENITY · Enbrel · GenVisc 850 · HUMIRA · Humira · ILARIS · INFLECTRA · KRYSTEXXA · LUPKYNIS · MONOVISC · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ORENCIA · PURIFIED CORTROPHIN GEL · REMICADE · RINVOQ · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · TALTZ · TEPEZZA · TERIPARATIDE · TREMFYA · Tymlos · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (63%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $9 per 100 Medicare services performed
Looking for a rheumatology in Aventura?
Compare rheumatologys in the Aventura area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
93
Per 100K population
3.5
County median income
$68,694
Nearest hospital
HCA FLORIDA AVENTURA HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gaylis is a mixed practice specialist, with above-average Medicare volume (top 7% in FL), and speaking/promotional industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gaylis experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Gaylis performed 84,041 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gaylis receive payments from pharmaceutical companies?
Yes. Dr. Gaylis received a total of $19,948 from 32 companies across 166 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gaylis's costs compare to other rheumatologys in Aventura?
Dr. Gaylis's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gaylis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →